Using a mucosal impedance device to help diagnose chronic esophageal problems

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational study that adds MuVI esophageal mucosal impedance measurements to standard upper endoscopy in participants with chronic esophageal symptoms. Measurements from the impedance device will be compared with endoscopic findings, biopsies, and available pH testing to determine diagnostic concordance. Investigators will also examine potential cost implications by considering whether the device could reduce the need for multiple procedures. Exclusion criteria include esophageal stricture, cancer, unstable condition, anticoagulation on the day of procedure, pregnancy, and minors.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1\. Patients with chronic esophageal symptoms such as atypical or typical reflux symptoms and dysphagia, is here for upper endoscopy testing.

Exclusion Criteria:

1. Presence of esophageal stricture
2. Unstable patients who cannot undergo this testing.
3. Patients on anticoagulation on the day of procedure.
4. Presence of esophageal cancer.
5. Pregnancy.
6. Minor patients.

Where it's running

• Froedtert Hospital
  Milwaukee, Wisconsin, United States Recruiting

Study contacts

• Study coordinator: Gokulakrishnan Balasubramanian
• Email: gbalasubramanian@mcw.edu
• Phone: 414-805-3827

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• A registry for adults with esophageal movement and reflux problems.

  This project will collect esophageal function tests (manometry, pH-impedance, FLIP) and clinical data from adults with reflux or swallowing symptoms to see if combining these results helps guide diagnosis and long-term care.

  Recruiting IRCCS San Raffaele · Milan, Lombardy · NCT07506746

• Thread-Embedding Acupuncture plus a Proton Pump Inhibitor for GERD

  This study tests whether adding thread-embedding acupuncture to standard omeprazole treatment helps people with GERD who have a traditional Liver-Stomach constraint-heat pattern.

  Recruiting University of Science Ho Chi Minh City · Ho Chi Minh City · NCT07797959

• Upadacitinib for Eosinophilic Esophagitis in adults not responding to standard therapy

  This study tests whether upadacitinib, taken with topical corticosteroids, can reduce disease activity in adults with eosinophilic esophagitis who still have symptoms.

  Recruiting Phase 2 University of North Carolina, Chapel Hill · Chapel Hill, North Carolina and 1 other locations · NCT07588568

• Transoral incisionless fundoplication (TIF) for GERD in Asian adults

  This tests whether a less-invasive transoral incisionless fundoplication (TIF) procedure can reduce reflux symptoms in Asian adults who continue to have GERD despite daily PPI treatment.

  Recruiting Phase 2 Chinese University of Hong Kong · Hong Kong · NCT07556289

• Diaphragm training for GERD symptoms

  This study will test whether diaphragm-focused breathing exercises or using a volume-based incentive spirometer can help people with GERD have fewer reflux episodes and better symptoms.

  Recruiting Changhua Christian Hospital · Changhua, Changhua County · NCT07544433

• Comparing Trimedat 76.95 mg orally disintegrating tablets with Trimedat 100 mg tablets in healthy adults

  This will test if Trimedat 76.95 mg dissolving tablets work the same and are as safe as Trimedat 100 mg tablets when taken fasting by healthy adults.

  Recruiting Phase 1 Valenta Pharm JSC · Saint Petersburg · NCT07421011

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.